• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Robert F. Kennedy Jr.

FDA
Favicon Fierce Pharma

FDA approves leucovorin without clinical trial—but not for autism

The FDA has used real-world data to approve leucovorin to treat cerebral folate deficiency in patients who have a confirmed variant in the FOLR1 gene.
Angus Liu , Darren Incorvaia Mar 10, 2026 9:00am
Albert Bourla Pfizer CEO Bourla
Favicon Fierce Pharma

Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad

Mar 3, 2026 4:58pm
The exterior of the Centers for Disease Control and Prevention campus in Chamblee Georgia March 18 2025
Favicon Fierce Healthcare

NIH Director Jay Bhattacharya to take over as temporary CDC head

Feb 18, 2026 4:30pm
FDA
Favicon Fierce Pharma

Vaccine makers facing increased volatility, uncertainty at FDA

Feb 13, 2026 11:12am
bacteria and virus science on chalkboard

US vaccine landscape ‘100%’ impacting business: Bancel

Jan 23, 2026 1:26pm
dominoes stop stall halt end red

NIH bans use of aborted fetal tissue in research

Jan 22, 2026 2:27pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings